Literature DB >> 26063425

Restriction of HIV-1 Requires the N-Terminal Region of MxB as a Capsid-Binding Motif but Not as a Nuclear Localization Signal.

Bianca Schulte1, Cindy Buffone1, Silvana Opp1, Francesca Di Nunzio2, Daniel Augusto De Souza Aranha Vieira1, Alberto Brandariz-Nuñez1, Felipe Diaz-Griffero3.   

Abstract

UNLABELLED: The interferon alpha (IFN-α)-inducible restriction factor MxB blocks HIV-1 infection after reverse transcription but prior to integration. Fate-of-capsid experiments have correlated the ability of MxB to block HIV-1 infection with stabilization of viral cores during infection. We previously demonstrated that HIV-1 restriction by MxB requires capsid binding and oligomerization. Deletion and gain-of-function experiments have mapped the HIV-1 restriction ability of MxB to its N-terminal 25 amino acids. This report reveals that the N-terminal 25 amino acids of MxB exhibit two separate functions: (i) the ability of MxB to bind to HIV-1 capsid and (ii) the nuclear localization signal of MxB, which is important for the ability of MxB to shuttle into the nucleus. To understand whether MxB restriction of HIV-1 requires capsid binding and/or nuclear localization, we genetically separated these two functions and evaluated their contributions to restriction. Our experiments demonstrated that the (11)RRR(13) motif is important for the ability of MxB to bind capsid and to restrict HIV-1 infection. These experiments suggested that capsid binding is necessary for the ability of MxB to block HIV-1 infection. Separately from the capsid binding function of MxB, we found that residues (20)KY(21) regulate the ability of the N-terminal 25 amino acids of MxB to function as a nuclear localization signal; however, the ability of the N-terminal 25 amino acids to function as a nuclear localization signal was not required for restriction. IMPORTANCE: MxB/Mx2 blocks HIV-1 infection in cells from the immune system. MxB blocks infection by preventing the uncoating process of HIV-1. The ability of MxB to block HIV-1 infection requires that MxB binds to the HIV-1 core by using its N-terminal domain. The present study shows that MxB uses residues (11)RRR(13) to bind to the HIV-1 core during infection and that these residues are required for the ability of MxB to block HIV-1 infection. We also found that residues (20)KY(21) constitute a nuclear localization signal that is not required for the ability of MxB to block HIV-1 infection.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26063425      PMCID: PMC4524248          DOI: 10.1128/JVI.00753-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

Review 1.  Dynamin-like MxA GTPase: structural insights into oligomerization and implications for antiviral activity.

Authors:  Otto Haller; Song Gao; Alexander von der Malsburg; Oliver Daumke; Georg Kochs
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  MxA inhibits hepatitis B virus replication by interaction with hepatitis B core antigen.

Authors:  Ning Li; Lei Zhang; Liangwei Chen; Wenfeng Feng; Yinfeng Xu; Feng Chen; Xiaohong Liu; Zhi Chen; Wei Liu
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

3.  Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes.

Authors:  Georg Kochs; Christian Janzen; Heinz Hohenberg; Otto Haller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

4.  The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleus.

Authors:  Henning Hofmann; Eric C Logue; Nicolin Bloch; Waaqo Daddacha; Sylvie B Polsky; Megan L Schultz; Baek Kim; Nathaniel R Landau
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

Review 5.  Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity.

Authors:  Otto Haller; Georg Kochs
Journal:  J Interferon Cytokine Res       Date:  2010-12-19       Impact factor: 2.607

6.  Myxovirus resistance gene A (MxA) expression suppresses influenza A virus replication in alpha interferon-treated primate cells.

Authors:  Shannon R Matzinger; Timothy D Carroll; Joseph C Dutra; Zhong-Min Ma; Christopher J Miller
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

7.  Inhibition of a large double-stranded DNA virus by MxA protein.

Authors:  Christopher L Netherton; Jennifer Simpson; Otto Haller; Thomas E Wileman; Haru-Hisa Takamatsu; Paul Monaghan; Geraldine Taylor
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

Review 8.  Mechanics of dynamin-mediated membrane fission.

Authors:  Sandrine Morlot; Aurélien Roux
Journal:  Annu Rev Biophys       Date:  2013       Impact factor: 12.981

9.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

10.  Role of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac.

Authors:  Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Tommy E White; Nadine Laguette; Monsef Benkirane; Jurgen Brojatsch; Felipe Diaz-Griffero
Journal:  Retrovirology       Date:  2012-06-12       Impact factor: 4.602

View more
  32 in total

Review 1.  Human MX2/MxB: a Potent Interferon-Induced Postentry Inhibitor of Herpesviruses and HIV-1.

Authors:  Peter Staeheli; Otto Haller
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

2.  MxB Restricts HIV-1 by Targeting the Tri-hexamer Interface of the Viral Capsid.

Authors:  Sarah Sierra Smaga; Chaoyi Xu; Brady James Summers; Katherine Marie Digianantonio; Juan R Perilla; Yong Xiong
Journal:  Structure       Date:  2019-05-30       Impact factor: 5.006

3.  Evolutionary Analyses Suggest a Function of MxB Immunity Proteins Beyond Lentivirus Restriction.

Authors:  Patrick S Mitchell; Janet M Young; Michael Emerman; Harmit S Malik
Journal:  PLoS Pathog       Date:  2015-12-10       Impact factor: 6.823

4.  Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid.

Authors:  Fengwen Xu; Fei Zhao; Xiaoxiao Zhao; Di Zhang; Xiaoman Liu; Siqi Hu; Shan Mei; Zhangling Fan; Yu Huang; Hong Sun; Liang Wei; Chao Wu; Quanjie Li; Jianwei Wang; Shan Cen; Chen Liang; Fei Guo
Journal:  J Biol Chem       Date:  2020-03-26       Impact factor: 5.157

5.  MxB Is Not Responsible for the Blocking of HIV-1 Infection Observed in Alpha Interferon-Treated Cells.

Authors:  Silvana Opp; Daniel A S A Vieira; Bianca Schulte; Sumit K Chanda; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

Review 6.  Capsid-Dependent Host Factors in HIV-1 Infection.

Authors:  Masahiro Yamashita; Alan N Engelman
Journal:  Trends Microbiol       Date:  2017-05-18       Impact factor: 17.079

7.  Modular HIV-1 Capsid Assemblies Reveal Diverse Host-Capsid Recognition Mechanisms.

Authors:  Brady J Summers; Katherine M Digianantonio; Sarah S Smaga; Pei-Tzu Huang; Kaifeng Zhou; Eva E Gerber; Wei Wang; Yong Xiong
Journal:  Cell Host Microbe       Date:  2019-08-14       Impact factor: 21.023

8.  The ability of SAMHD1 to block HIV-1 but not SIV requires expression of MxB.

Authors:  Cindy Buffone; Juliane Kutzner; Silvana Opp; Alicia Martinez-Lopez; Anastasia Selyutina; Si Ana Coggings; Lydia R Studdard; Lingmei Ding; Baek Kim; Paul Spearman; Torsten Schaller; Felipe Diaz-Griffero
Journal:  Virology       Date:  2019-03-30       Impact factor: 3.616

Review 9.  A self-encoded capsid derivative restricts Ty1 retrotransposition in Saccharomyces.

Authors:  David J Garfinkel; Jessica M Tucker; Agniva Saha; Yuri Nishida; Katarzyna Pachulska-Wieczorek; Leszek Błaszczyk; Katarzyna J Purzycka
Journal:  Curr Genet       Date:  2015-12-09       Impact factor: 3.886

10.  Porcine Mx1 Protein Inhibits Classical Swine Fever Virus Replication by Targeting Nonstructural Protein NS5B.

Authors:  Jing Zhou; Jing Chen; Xiao-Min Zhang; Zhi-Can Gao; Chun-Chun Liu; Yun-Na Zhang; Jin-Xiu Hou; Zhao-Yao Li; Lin Kan; Wen-Liang Li; Bin Zhou
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.